Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Sept 2026 for Elevance Health, Inc., €33k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Erin M. Wessling: trading record in brief
All filings by Erin M. Wessling on record concern Elevance Health, Inc. Over a trading history stretching from 2 September 2025 to 3 September 2026, the count stands at 6 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 4 September 2026, reports a share grant of €33k in Elevance Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Erin M. Wessling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
94 shares@ US$405.840.0000% mcap19.8% of flowCommon StockSEC:0002084548-26-000005:0
255 shares@ US$414.780.0001% mcap54.9% of flowCommon StockSEC:0002084548-26-000005:1
2,976 shares0Common StockSEC:0002084548-26-000002:0
152 shares@ US$321.59100.0% of flowCommon StockSEC:0002084548-25-000004:0
931 shares0Common StockSEC:0002084548-25-000002:0
5 of 5 declarations
